IRADIMED CORP·4

Mar 10, 4:05 PM ET

Susi Roger E. 4

Research Summary

AI-generated summary

Updated

IRADIMED (IRMD) 10% Owner Roger E. Susi Sells Shares

What Happened Roger E. Susi, identified as a 10% owner of IRADIMED Corp (IRMD), sold a total of 7,500 shares in open-market transactions. On 2026-03-09 he sold 5,000 shares at an average price of $100.04 for proceeds of $500,200, and on 2026-03-10 he sold 2,500 shares at an average price of $100.11 for proceeds of $250,275 — total proceeds ≈ $750,475. These were sales (dispositions), which are often routine rather than a bullish signal.

Key Details

  • Transaction dates and amounts:
    • 2026-03-09: 5,000 shares sold — weighted avg price reported $100.04 — proceeds $500,200 (see footnote F2 for trade range details).
    • 2026-03-10: 2,500 shares sold — weighted avg price reported $100.11 — proceeds $250,275 (see footnote F3 for trade range details).
  • Total shares sold: 7,500; total proceeds: ~$750,475.
  • Shares owned after the transactions: Not disclosed in the provided Form 4.
  • Notable footnotes:
    • F1: Sales were effected under a Rule 10b5-1 trading plan adopted Nov 5, 2025 (pre-set plan).
    • F2/F3: Each reported sale was executed in multiple trades; the reported prices are weighted averages and the filer will provide detailed trade-by-trade prices upon request.
    • F4: Reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
  • Filing timeliness: Form 4 was filed 2026-03-10 covering the reported transactions; this appears to be filed promptly.

Context

  • A 10b5-1 plan indicates these sales were made according to a pre-established schedule, which often reduces the informational significance of the transactions (they may not reflect the insider’s current view of the company).
  • As a 10% owner, Susi is a substantial shareholder; disposals by large holders can be for many reasons (portfolio management, diversification, taxes) and do not necessarily indicate a change in company fundamentals.